Study Watch with Irregular Pulse Monitor (Home) vs ClearRead CT

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Study Watch with Irregular Pulse Monitor (Home)

by Verily Health

ClearRead CT

by RIVERAIN TECHNOLOGIES

AI Verdict

These tools address different aspects of cardiovascular health through distinct methodologies. Tool A is a wearable device focused on remote physiological monitoring, specifically for irregular pulse detection and ECG measurements. In contrast, Tool B is an AI-powered software designed to analyze CT scans for the detection of pulmonary nodules and coronary artery calcification, primarily supporting diagnostic imaging workflows.

Choose Study Watch with Irregular Pulse Monitor (Home) if…

Choose the Verily Study Watch with Irregular Pulse Monitor if your primary need is continuous, long-term, and unobtrusive remote physiological monitoring for clinical research or managing patients with potential or diagnosed irregular heart rhythms like AFib in a home setting. This prescription-only wearable excels at collecting real-world ECG and other vital data over extended periods, leveraging cloud-based analytics for comprehensive insights.

View Study Watch with Irregular Pulse Monitor (Home) →

Choose ClearRead CT if…

Choose ClearRead CT if your objective is to enhance the diagnostic accuracy and efficiency of cardiothoracic CT scan interpretation within a radiology workflow. This AI suite is specifically designed to improve the detection and characterization of pulmonary nodules and facilitate coronary artery calcification scoring, ultimately reducing reading times and aiding radiologists in making more confident diagnoses.

View ClearRead CT →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Study Watch with Irregular Pulse Monitor (Home)	ClearRead CT
Pricing	Unknown	Contact for pricing
Deployment	Unknown	On-premise (stand-alone server, virtual machine) and Cloud
FDA Status	Unknown	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools demonstrate strong usability for their intended users. Tool A focuses on patient ease of use for data collection, emphasizing unobtrusiveness and accessibility for diverse demographics through physical buttons and minimal on-device content. Tool B prioritizes radiologist workflow integration, reducing reading time and cognitive burden by seamlessly integrating with existing PACS systems without requiring a separate viewer.

Clinical Value

ClearRead CT

Tool B demonstrates a more direct and quantifiable clinical impact by significantly improving pulmonary nodule detection rates, with a 29% reduction in missed actionable nodules and increased detection of small nodules (u22642 mm). It also reduces reading times for radiologists by up to 36%. While Tool A provides valuable physiological data for AFib detection and clinical research, Tool B's immediate and measurable enhancement of diagnostic accuracy in a critical area like cancer screening gives it an edge.

Pricing & Value

Tie

Both Tool A and Tool B explicitly state 'contact for pricing' and do not provide publicly available pricing details. This lack of transparency for both products makes it impossible to conduct a head-to-head comparison on their pricing structures or assess their value proposition relative to cost.

Enterprise Readiness

ClearRead CT

Tool B demonstrates stronger enterprise readiness with its explicit 'Enterprise-wide capability on every CT device,' flexible on-premise and cloud deployment options, and seamless PACS integration. Its proven adoption in institutions like the VA and expansion across multiple countries further validate its ability to scale and integrate into complex healthcare environments. While Tool A is used in large-scale clinical studies, Tool B's direct integration into core clinical workflows and broader deployment flexibility give it an advantage.

Innovation

ClearRead CT

Tool B showcases significant innovation with its 'patented Vessel Suppression (Clear Visual Intelligence)' technology, which directly enhances the visibility and detection of pulmonary nodules by removing interfering structures. This specialized AI-driven image processing represents a distinct technological advancement in radiology. While Tool A offers innovative unobtrusive multi-sensor data collection for research, Tool B's unique and patented approach to image enhancement provides a more specific and impactful technological innovation in its domain.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offer specific details regarding the support services or documentation available for either Tool A or Tool B. Without this information, it is impossible to distinguish between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Study Watch with Irregular Pulse Monitor (Home)	ClearRead CT
Product Name	Study Watch with Irregular Pulse Monitor (Home)	ClearRead CT
Company	Verily Life Sciences LLC	RIVERAIN TECHNOLOGIES
Primary Function	Prescription-only wearable device for clinical research and healthcare use, designed to unobtrusively collect physiological data, including ECG and irregular pulse monitoring.	FDA-cleared AI suite for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans.
Key Feature: Cardiac Monitoring / Nodule Detection	On-demand single-channel ECG measurement; Irregular pulse monitoring for atrial fibrillation (AFib) detection.	Pulmonary Nodule Detection (solid, part-solid, ground glass); Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs).
Key Feature: Sensor Data / Image Enhancement	Multiple physiological sensors (heart rate, electrodermal activity, inertial movements); Environmental sensors.	Patented Vessel Suppression (Clear Visual Intelligence).
Supported Specialties	Cardiology, Family Medicine, Internal Medicine	Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Study Watch with Irregular Pulse Monitor (Home) and ClearRead CT.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into distinct clinical workflows, and for what specific patient populations or diagnostic challenges are they best suited?

Tool A, the Verily Study Watch, is designed for unobtrusive, continuous physiological data collection, including ECG and irregular pulse monitoring, making it suitable for remote patient monitoring and clinical research, particularly for conditions like atrial fibrillation and Parkinson's disease. Tool B, ClearRead CT, is an AI suite that integrates seamlessly into radiology PACS workflows to enhance the interpretation of CT scans for pulmonary nodule detection and coronary artery calcification analysis, primarily benefiting radiologists, pulmonologists, and cardiologists in diagnostic settings.

What is the depth of EHR integration for each tool, and how does data flow from the device/AI analysis into a patient's electronic health record?

For the Verily Study Watch, data is collected on the device, encrypted, and processed in the cloud using proprietary algorithms and machine learning. Verily's platform, Pre, is designed to ingest and harmonize data from various sources, including wearables, for research and clinical workflows, implying a structured approach to data management that could facilitate EHR integration. ClearRead CT emphasizes seamless PACS integration, meaning post-processed images and analysis results, including nodule measurements and CAC scores, are directly stored into the PACS, from where they can be accessed and potentially flow into the EHR.

What are the reported accuracy and sensitivity metrics for each tool in their respective clinical applications?

The Verily Study Watch has demonstrated high accuracy in identifying atrial fibrillation, with studies reporting 96.1% sensitivity and 98.1% specificity for interval-level AF detection. ClearRead CT has shown significant improvements in diagnostic accuracy, with reported benefits including a 29% reduction in missed actionable nodules and high agreement with radiologists for CAC scoring (0.959 agreement).

What is the expected learning curve for clinicians and support staff, and what is the typical time-to-value for each tool?

ClearRead CT is designed for easy installation and seamless integration into existing PACS systems, allowing radiologists to view AI-processed images alongside traditional scans without needing a separate viewer, which suggests a potentially fast time-to-value due to minimal workflow disruption and reported reductions in reading time (up to 36%). For the Verily Study Watch, while the device itself is unobtrusive for patients, the learning curve for clinicians would likely involve understanding the cloud-based analytics platform and integrating the interpretation of continuous physiological data into patient management, with time-to-value tied to the efficiency of data review and actionable insights for conditions like AFib.

Beyond standard compliance, what specific security features and audit-trail capabilities do these tools offer to protect patient data and ensure accountability?

The Verily Study Watch features on-device data encryption for security, with all collected data encrypted before being uploaded and processed in the cloud. Verily also adheres to industry-recognized security frameworks like SOC 2 Type II and ISO/IEC 27001, implementing strong encryption (in-transit and at-rest), tightly restricted role-based access, and empowering users to manage data access. ClearRead CT, while integrated into PACS, offers audit-trail features through its integration with enterprise AI infrastructures like deepcOS, which provides centralized governance and monitoring to ensure consistent quality and compliance.

Are customer references or case studies available to understand real-world implementation experiences, and what level of ongoing technical and clinical support is provided?

Riverain Technologies highlights that ClearRead CT is used by leading healthcare organizations globally, with case studies and peer-reviewed clinical evidence available to validate its effectiveness and real-world success. For the Verily Study Watch, its use in various Verily-led observational studies, including the Personalized Parkinson's Project and the Baseline Study, serves as real-world implementation experience, and Verily offers comprehensive clinical trial support across regulatory, development, operations, and compliance.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Study Watch with Irregular Pulse Monitor (Home) or ClearRead CT

Backers

Who funded each tool's parent company.